Gonadal tumors of mice double transgenic for inhibin-α promoter-driven simian virus 40 T-antigen and herpes simplex virus thymidine kinase are sensitive to ganciclovir treatment

Journal of Endocrinology

Volumn 170, Issue 1, 2001, Pages 79-90

  Mikola, M K ^a   Rahman, N A ^a   Paukku, T H ^a   Ahtiainen, P M ^a   Vaskivuo, T E ^a   Tapanainen, J S ^a   Poutanen, M ^a   Huhtaniemi, I T ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ESTRADIOL; GANCICLOVIR; INHIBIN A; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE; THYMIDINE KINASE; VIRUS T ANTIGEN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROSS BREEDING; DOSE RESPONSE; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FUSION GENE; GENE EXPRESSION; GENE THERAPY; GONAD TUMOR; GRANULOSA CELL; HERPES SIMPLEX VIRUS; IN VITRO STUDY; LEYDIG CELL; MALE; MOUSE; NONHUMAN; ORGAN SIZE; OVARY TUMOR; PRIORITY JOURNAL; SIMIAN VIRUS 40; SOMATIC CELL; TESTIS TUMOR; TRANSGENIC MOUSE; TUMOR CELL; TUMOR VOLUME;

ACYCLOVIR; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIVIRAL AGENTS; APOPTOSIS; BREEDING; FEMALE; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GRANULOSA CELL TUMOR; INHIBINS; LEYDIG CELL TUMOR; MALE; MICE; MICE, TRANSGENIC; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIMPLEXVIRUS; TESTICULAR NEOPLASMS; THYMIDINE KINASE;

EID: 0034923861     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1700079     Document Type: Article

References (57)

1. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter
2. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system
3. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand independent death receptor aggregation and activation of caspases
4. Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis
5. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-tk retroviral gene therapy
6. Implementing transgenic embryonic stem cell technology to study gene expression, cell-cell interactions and gene function
7. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
8. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy
9. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the 'bystander effect'
10. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
11. Combination gene therapy for liver metastasis of colon carcinoma in vivo
12. Metabolism of 9-(1,3-dihydroxy-2-propoxy-methyl) guanine, a new anti-herpes simplex virus compound, in herpes simplex virus-infected cells
13. The 'bystander effect': Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice
14. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumor
15. The biochemistry and mechanism of action of acyclovir
16. The extent of heterocellular communication mediated by gap junctions is predictive of bystander cytotoxicity in vitro
17. Tumor regression when a fraction of the tumor mass contains the HSV-TK gene
18. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
19. The treatment of ovarian cancer with a gene modified cancer vaccine: A phase 1 study
20. Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpes virus genetic information
21. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
22. A supersensitive immunofluorometric assay for rat luteinizing hormone
23. Treatment of prostatic cancer patients with a gonadotropin-releasing hormone agonist analog: Acute and long term effects on endocrine functions of testis tissue
24. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: Reevaluation by highly sensitive immunometric assay
25. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin α-subunit promoter/Simian virus T-antigen fusion gene: Characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines
26. The mouse inhibin α-subunit promoter directs SV40 T-antigen to Leydig cells of transgenic mice
27. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities
28. Animal models in drug development
29. Gene therapists test puzzling 'bystander effect'
30. Cancer gene therapy with HSV-tk/ GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo
31. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene
32. Two-drug combinations that increase apoptosis and modulate bak and bcl-X(L) expression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase
33. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl) guanine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine
34. The FSH β-subunit promoter directs the expression of Herpes simplex virus type I thymidine kinase to the testis of transgenic mice
35. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase
36. Tumor Chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
37. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
38. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
39. Anticellular effects of 9-(2-hydroxyethoxymethyl) guanine against herpes simplex virus-transformed cells
40. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir
41. Cancer gene therapy: A bystander effect using the gap junctional pathway
42. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect
43. In situ retroviral mediated gene transfer for the treatment of brain tumors in rats
44. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
45. Herpes simplex virus type 1 DNA polymerase: Mechanism of inhibition by acyclovir triphosphate
46. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-β-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: A novel paradigm for cell killing
47. 'Bystander killing' induces apoptosis and is inhibited by forskolin
48. Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpes virus genetic information
49. Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells
50. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy
51. Adenoviral vectors for gene transfer
52. Apoptosis and apoptosis-related proteins in human endometrium
53. Daily measurements of salivary progesterone reveal high rate of anovulation in healthy students
54. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase
55. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: The Good Samaritan effect
56. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells